ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System [Yahoo! Finance]
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan [Seeking Alpha]